SG2013079843A - Use of tocotrienols in the treatment or prevention of ulcerative colitis - Google Patents

Use of tocotrienols in the treatment or prevention of ulcerative colitis

Info

Publication number
SG2013079843A
SG2013079843A SG2013079843A SG2013079843A SG2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A SG 2013079843 A SG2013079843 A SG 2013079843A
Authority
SG
Singapore
Prior art keywords
tocotrienols
prevention
treatment
ulcerative colitis
ulcerative
Prior art date
Application number
SG2013079843A
Inventor
Chee Wai Fong
Tzuen Yih Saw
Original Assignee
Davos Life Science Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Davos Life Science Pte Ltd filed Critical Davos Life Science Pte Ltd
Priority to SG2013079843A priority Critical patent/SG2013079843A/en
Priority to PCT/SG2014/000500 priority patent/WO2015060789A1/en
Publication of SG2013079843A publication Critical patent/SG2013079843A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG2013079843A 2013-10-25 2013-10-25 Use of tocotrienols in the treatment or prevention of ulcerative colitis SG2013079843A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SG2013079843A SG2013079843A (en) 2013-10-25 2013-10-25 Use of tocotrienols in the treatment or prevention of ulcerative colitis
PCT/SG2014/000500 WO2015060789A1 (en) 2013-10-25 2014-10-24 Use of tocotrienols in the treatment or prevention of ulcerative colitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG2013079843A SG2013079843A (en) 2013-10-25 2013-10-25 Use of tocotrienols in the treatment or prevention of ulcerative colitis

Publications (1)

Publication Number Publication Date
SG2013079843A true SG2013079843A (en) 2015-05-28

Family

ID=52993257

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2013079843A SG2013079843A (en) 2013-10-25 2013-10-25 Use of tocotrienols in the treatment or prevention of ulcerative colitis

Country Status (2)

Country Link
SG (1) SG2013079843A (en)
WO (1) WO2015060789A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018005412A1 (en) * 2016-06-28 2018-01-04 Tien Yang Der Chemoprotective/chemoactive nanodroplets and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214373B1 (en) * 1999-10-07 2001-04-10 Snowden-Sutton Associates, Inc. Nutritional composition for treating inflammatory bowel diseases
US20050107465A1 (en) * 2003-10-01 2005-05-19 Papas Andreas M. Composition for treating inflammatory bowel disease

Also Published As

Publication number Publication date
WO2015060789A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
IL281793A (en) Use of cannabinoids in the treatment of epilepsy
HK1253580A1 (en) Use of cannabinoids in the treatment of epilepsy
PT3334422T (en) Use of cannabinoids in the treatment of epilepsy
PL3157512T3 (en) Use of cannabidiol in the treatment of epilepsy
HK1223616A1 (en) Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections hiv
HK1223615A1 (en) Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections hiv
EP2954376A4 (en) Fluid treatment methods and systems
GB201400442D0 (en) Compositions for use in the treatment of ulcerative colitis
HUE044216T2 (en) Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
EP3030343A4 (en) Novel fluid treatment systems and methods
IL252493A0 (en) Compounds for use in the prevention or treatment of cancer
SG2013079843A (en) Use of tocotrienols in the treatment or prevention of ulcerative colitis
PL2862576T3 (en) Microorganisms and compositions comprising them for use in the treatment or prevention of mastitis
HK1209033A1 (en) Use of odiparcil in the treatment of mucopolysaccharidosis
AP2015008726A0 (en) Low-glycerin-formulations for hiv treatment and prevention
HUE047636T2 (en) Arginine for use in the treatment and/or prevention of osteoarthritis
PL3041459T3 (en) Compositions useful in the prevention or treatment of skin cancer
GB201421889D0 (en) Improvements in or relating to effluent treatment
GB201312597D0 (en) TrailerSafe reversing and safety aid
GB201319614D0 (en) Fluid treatment